Reports for PURDUE PHARMA
Company Name
PURDUE PHARMA
Totals |
||
Shortage reports |
140 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 139 (99%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 5 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYDROMORPH CONTIN | 4.5MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-06-03 | 2021-07-09 | 140262 |
| HYDROMORPH CONTIN | 4.5MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-07-21 | 2021-08-12 | 142841 |
| HYDROMORPH CONTIN | 4.5MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-06-23 | 2022-07-04 | 163380 |
| HYDROMORPH CONTIN | 4.5MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-10-27 | 2022-11-17 | 172766 |
| HYDROMORPH CONTIN | 4.5MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-12-15 | 2023-01-17 | 178602 |
| HYDROMORPH CONTIN | 9MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-02-22 | 2021-03-02 | 134480 |
| HYDROMORPH CONTIN | 9MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-04-15 | 2021-04-27 | 137503 |
| HYDROMORPH CONTIN | 9MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-09-29 | 2021-11-04 | 146370 |
| HYDROMORPH CONTIN | 9MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-04-28 | 2022-05-18 | 159614 |
| HYDROMORPH CONTIN | 9MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-06-16 | 2022-08-13 | 162712 |
| DILAUDID | 8MG | TABLET | Resolved | 2022-10-27 | 2022-11-11 | 172769 |
| MS CONTIN | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-10 | 2022-12-08 | 174235 |
| MS CONTIN | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-04 | 2021-10-02 | 143634 |
| MS CONTIN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-10 | 2022-12-08 | 174238 |
| MS.IR | 10MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2024-03-21 | 2024-03-28 | 222882 |
| MS.IR | 30MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2019-12-20 | 2020-03-23 | 101855 |
| MS.IR | 10MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-07-26 | 2021-12-10 | 143048 |
| MS.IR | 5MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-06-08 | 2021-07-16 | 140579 |
| MS.IR | 5MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-09-13 | 2021-10-08 | 145564 |
| MS.IR | 5MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-12-02 | 2021-12-22 | 150361 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BELBUCA | 75MCG | FILM, SOLUBLE | Discontinued | 2019-03-28 | 2019-04-02 | 79766 |
| BELBUCA | 150MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80230 |
| BELBUCA | 300MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80233 |
| BELBUCA | 450MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80236 |
| DILAUDID | 1MG | Discontinued | 2018-03-01 | 2018-03-02 | 41479 |
Showing 1 to 5 of 5